×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.48 | 91.3 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| PROCTER & GAMBLE HEALTH LIMITE | NA | NA | NA | NA | 9,554 | 36.7 |
| ACUTAAS CHEMICALS LIMITED | 3,142.63 | 627.16 | 3,084.83 | 7.80 | 9385 | 59.1 |
| SHILPA MEDICARE LTD. | 3,383.78 | 145.09 | 3,308.05 | 1.48 | 8791 | 98.2 |
PROCTER & GAMBLE HEALTH LIMITED, with Security Code 500126, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 297.6 | 310.0 | 320.9 | 301.2 | 304.9 | 310.0 | 252.5 | 283.9 | 313.4 | 309.8 |
| Expenses | 206.7 | 199.6 | 243.4 | 256.0 | 216.3 | 208.3 | 185.0 | 235.6 | 199.4 | 186.3 |
| Operating Profit | 90.8 | 110.4 | 77.5 | 45.2 | 88.7 | 101.7 | 67.4 | 48.3 | 114.0 | 123.4 |
| OPM % | 30.52% | 35.61% | 24.16% | 15.01% | 29.08% | 32.79% | 26.71% | 17% | 36.39% | 39.85% |
| Other Income | 3.4 | 4.5 | 5.0 | 5.5 | 6.1 | 5.2 | 2.3 | -18.1 | 3.3 | 4.0 |
| Interest | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Depreciation | 7.5 | 9.8 | 3.8 | 6.4 | 6.5 | 6.9 | 6.8 | 7.2 | 5.8 | 5.6 |
| Profit before tax | 86.6 | 104.9 | 78.5 | 44.1 | 88.1 | 99.7 | 62.7 | 43.0 | 111.4 | 121.7 |
| Tax % | -26.5% | -26.8% | -24.6% | -32.4% | -25.5% | -27.7% | -25.8% | 26.5% | 26.1% | -25.3% |
| Net Profit | 63.7 | 76.8 | 59.2 | 29.8 | 65.6 | 72.1 | 46.6 | 16.8 | 82.3 | 90.9 |
| EPS in Rs | 38.3 | 46.3 | 35.7 | 17.96 | 39.5 | 43.4 | 28 | 10.11 | 49.6 | 54.76 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | -24% |
| 3 Years: | 7% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| 1 Year: | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|